Gerald L. Ray & Associates’s CorMedix CRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$30K Sell
11,400
-14,000
-55% -$29K ﹤0.01% 327
2017
Q2
$54K Sell
25,400
-6,400
-20% -$21.9K 0.01% 322
2017
Q1
$259K Sell
31,800
-2,400
-7% -$22.9K 0.04% 281
2016
Q4
$262K Sell
34,200
-1,400
-4% -$14.2K 0.04% 269
2016
Q3
$449K Buy
35,600
+9,600
+37% +$89.7K 0.07% 211
2016
Q2
$259K Sell
26,000
-2,100
-7% -$32K 0.04% 265
2016
Q1
$372K Buy
28,100
+7,200
+34% +$69.9K 0.06% 210
2015
Q4
$212K Sell
20,900
-4,940
-19% -$56.9K 0.03% 284
2015
Q3
$257K Buy
25,840
+2,800
+12% +$43.2K 0.04% 251
2015
Q2
$447K Buy
23,040
+19,120
+488% +$656K 0.07% 212
2015
Q1
$193K Buy
3,920
+900
+30% +$21.3K 0.03% 302
2014
Q4
$29K Sell
3,020
-200
-6% -$1.59K ﹤0.01% 299
2014
Q3
$30K Hold
3,220
﹤0.01% 298
2014
Q2
$29K Buy
3,220
+950
+42% +$8.1K ﹤0.01% 302
2014
Q1
$28K Buy
+2,270
New +$26.7K 0.01% 286

Other funds holding CRMD